In two recent large studies, the prevalence of GPVs in ATM reported by Dorling et al. and Hu et al. was 0.60% and 0.78%, respectively, in unselected BC patients, whereas that in unaffected women was 0.29% and 0.41%, respectively [12,13] (Table 1). This evidence concerns the gene ATM and breast cancer.